HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hartis, C. E. Articles by Lederer, J. W. Search for Related Content PubMed PubMed Citation Articles by Hartis, C. E. Articles by Lederer, J. W., Jr.

CHARLES E. HARTIS, PHARM.D., is Clinical Pharmacist, Forsyth Medical Center, Winston-Salem, NC. MICHAEL O. GUM, PHARM.D., is Clinical Pharmacist, Presbyterian Hospital, Charlotte, NC. JAMES W. LEDERER, JR., M.D., is Medical Director, Clinical Improvement, Novant Health, Winston-Salem, NC.

Address correspondence to Dr. Hartis at Forsyth Medical Center, 3333 Silas Creek Parkway, Winston-Salem, NC 27103 (cehartis{at}novanthealth.org).

Purpose. The use of specific indicators, or "triggers," to identify adverse drug events (ADEs) associated with warfarin therapy is described. Summary. Automated triggers provided by laboratory and pharmacy data were used to identify potential ADEs associated with warfarin therapy among patients treated in the emergency room or admitted to six community hospitals between July 2002 and December 2003. The triggers consisted of an International Normalized Ratio (INR) of greater than 3.0 and pharmacy orders for vitamin K. Pharmacists reviewed the triggers monthly for clinical determination of ADEs during preintervention and postintervention periods. Interventions consisted of staff education and real-time adjustments in therapy. A 39% overall reduction in ADEs occurred between the preintervention and postintervention periods. Harmful ADEs declined by 70%. Conclusion. INRs of greater than 3.0 and vitamin K administration appeared to be reliable indicators of warfarin-associated ADEs, and detection with these indicators appeared to reduce ADEs when combined with appropriate interventions. Index terms: Anticoagulants; Dosage; Education; Health professions; International Normalized Ratio; Phytonadione; Toxicity; Vitamins; Warfarin

 

This article has been cited by other articles:

				S. M Handler, R. L Altman, S. Perera, J. T Hanlon, S. A Studenski, J. E Bost, M. I Saul, and D. B Fridsma A Systematic Review of the Performance Characteristics of Clinical Event Monitor Signals Used to Detect Adverse Drug Events in the Hospital Setting JAMIA, July 1, 2007; 14(4): 451 - 458. [Abstract] [Full Text] [PDF]